Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioNTech SE BNTX

Healthcare Biotechnology
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a... see more

Recent & Breaking News (NDAQ:BNTX)

BNTX Investors Have Opportunity to Lead BioNTech SE Securities Fraud Lawsuit

PR Newswire March 5, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTech SE of Class Action Lawsuit and Upcoming Deadlines - BNTX

Newsfile March 5, 2024

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in BioNTech SE with Losses of $100,000 to Contact the Firm

Newsfile March 5, 2024

The Gross Law Firm Reminds BioNTech SE Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 12, 2024 - BNTX

PR Newswire March 5, 2024

Levi & Korsinsky Reminds BioNTech Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 12, 2024 - BNTX

Accesswire March 5, 2024

Shareholders that lost money on BioNTech SE (BNTX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

Accesswire March 5, 2024

IMMINENT BNTX DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds BioNTech SE Investors to Join the Class Action Lawsuit!

Accesswire March 5, 2024

BioNTech Deadline Alert

Newsfile March 4, 2024

Class Action Filed Against BioNTech SE (BNTX) Seeking Recovery for Investors - Contact Levi & Korsinsky

Accesswire March 4, 2024

Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Against BioNTech SE (BNTX) and Urges BNTX Investors with Substantial Losses to Contact the Firm

Business Wire March 4, 2024

BioNTech SE Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 12, 2024 to Discuss Your Rights - BNTX

Accesswire March 4, 2024

Shareholders that lost money on BioNTech SE (BNTX) should contact Levi & Korsinsky about pending Class Action - BNTX

Accesswire March 4, 2024

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in BioNTech SE with Losses of $100,000 to Contact the Firm

Newsfile March 4, 2024

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioNTech SE(BNTX) Shareholders

Accesswire March 4, 2024

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 12, 2024 in BioNTech SE Lawsuit - BNTX

Accesswire March 4, 2024

BioNTech SE Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - BNTX

Accesswire March 4, 2024

IMMINENT BNTX DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds BioNTech SE Investors to Join the Class Action Lawsuit!

Accesswire March 4, 2024

BNTX Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of BioNTech SE (BNTX) of Deadline in Securities Fraud Class Action Lawsuit

Accesswire March 3, 2024

Class Action Filed Against BioNTech SE (BNTX) Seeking Recovery for Investors - Contact Levi & Korsinsky

Accesswire March 3, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTech SE of Class Action Lawsuit and Upcoming Deadlines - BNTX

PR Newswire March 3, 2024